Almac Discovery Ltd. - Product Pipeline Review - 2012

Global Markets Direct, July 2012, Pages: 28

Almac Discovery Ltd. – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “Almac Discovery Ltd. - Product Pipeline Review - 2012” provides data on the Almac Discovery Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Almac Discovery Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Almac Discovery Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Almac Discovery Ltd. - Brief Almac Discovery Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Almac Discovery Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Almac Discovery Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Almac Discovery Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Almac Discovery Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Almac Discovery Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Almac Discovery Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Almac Discovery Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Almac Discovery Ltd. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Almac Discovery Ltd.; Almac Discovery Ltd. - Key Therapeutics; Almac Discovery Ltd. - Pipeline Overview and Promising Molecules; Almac Discovery Ltd. - News; Almac Discovery Ltd. - Latest Updates; Almac Discovery Ltd. - Pipeline; Almac Discovery Ltd. - Discontinued/Dormant Projects

2
List of Tables 3
List of Figures 4
Almac Discovery Ltd. Snapshot 5
Almac Discovery Ltd. Overview 5
Key Information 5
Key Facts 5
Almac Discovery Ltd. – Research and Development Overview 6
Key Therapeutic Areas 6
Almac Discovery Ltd. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Almac Discovery Ltd. – Pipeline Products Glance 10
Almac Discovery Ltd. Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Almac Discovery Ltd. – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Almac Discovery Ltd. – Drug Profiles 13
ALM101 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ALM201 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ALM301 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Novel Targets For Oncology 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Almac Discovery Ltd. – Pipeline Analysis 17
Almac Discovery Ltd. – Pipeline Products by Therapeutic Class 17
Almac Discovery Ltd. – Pipeline Products By Target 18
Almac Discovery Ltd. – Pipeline Products by Route of Administration 19
Almac Discovery Ltd. – Pipeline Products By Mechanism of Action 20
Almac Discovery Ltd. - Discontinued Pipeline Products 21
Discontinued Pipeline Product Profiles 21
AD01 21
Almac Discovery Ltd. – Locations And Subsidiaries 22
Head Office 22
Financial Deals Landscape 23
Almac Discovery Ltd., Deals Summary 23
Almac Discovery Ltd., Pharmaceuticals & Healthcare, Deal Details 24
Partnerships 24
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 24
Almac Discovery Enters Into Co-Development Agreement With Immune Therapy 25
Licensing Agreements 26
Archimedes Development Enters Into Licensing Agreement With Almac Discovery 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables
Almac Discovery Ltd., Key Information 5
Almac Discovery Ltd., Key Facts 5
Almac Discovery Ltd. – Pipeline by Indication, 2012 7
Almac Discovery Ltd. – Pipeline by Stage of Development, 2012 8
Almac Discovery Ltd. – Monotherapy Products in Pipeline, 2012 9
Almac Discovery Ltd. – Phase I, 2012 10
Almac Discovery Ltd. – Pre-Clinical, 2012 11
Almac Discovery Ltd. – Discovery, 2012 12
Almac Discovery Ltd. – Pipeline By Therapeutic Class, 2012 17
Almac Discovery Ltd. - Pipeline By Target, 2012 18
Almac Discovery Ltd. – Pipeline By Route of Administration, 2012 19
Almac Discovery Ltd. – Pipeline Products By Mechanism of Action, 2012 20
Almac Discovery Ltd. - Discontinued Pipeline Products, 2012 21
Almac Discovery Ltd., Deals Summary 23
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 24
Almac Discovery Enters Into Co-Development Agreement With Immune Therapy 25
Archimedes Development Enters Into Licensing Agreement With Almac Discovery 26

List of Figures
Almac Discovery Ltd. – Pipeline by Indication, 2012 7
Almac Discovery Ltd. – Pipeline by Stage of Development, 2012 8
Almac Discovery Ltd. – Monotherapy Products in Pipeline, 2012 9
Almac Discovery Ltd. – Pipeline By Therapeutic Class, 2012 17
Almac Discovery Ltd. - Pipeline By Target, 2012 18
Almac Discovery Ltd. – Pipeline By Route of Administration, 2012 19
Almac Discovery Ltd. - Pipeline Products By Mechanism of Action, 2012 20

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Abbott Laboratories - IT Sales Opportunities - 2009
• eBay - Strong Execution
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• Scientific Games Corporation - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• Ixia - Company Analysis